| 英文社名 | Zhejiang Taimei Medical Technology Co., Ltd. |
|---|---|
| 所在地 | 19/F, Golden Centre, 188 Des Voeux Road Central, Hong Kong |
| URL | http://www.taimei.com |
| 上場年 | 2024年10月 |
| 決算期 | 2025年12月 |
| 株主 |
ZHAO Lu & Associates (Total share: 31.83%); (H share: 0.61%) [00700] Tencent Holdings Limited (Total share: 11.51%); (H share: 6.48%) ZUO Lingye & Associates (Total share: 9.58%); (H share: 15.00%) Zhang Pengpeng (Total share: 2.83%); (H share: 7.95%) Shanghai Xingpan Investment Management Consulting Co., Ltd. (Total share: 2.76%); (H share: 7.75%) Shanghai Xingshang Enterprise Management Consulting Co., Ltd. (Total share: 2.36%); (H share: 6.63%) Zhang Xu & Associates (Total share: 2.18%); (H share: 6.13%) Shanghai Chenxi Venture Capital Center (Limited Partnership) (Total share: 2.04%); (H share: 5.75%) Yan Andrew Y (Total share: 1.93%); (H share: 5.43%) Ningbo Meishan Bonded Area Dirui Investment Management Partnership (Limited Partnership) (Total share: 1.90%); (H share: 5.34%) Zheshang Venture Capital Co., Ltd. (Total share: 1.79%); (H share: 5.04%) |
| 上場株式数 | 200,425,133 |
| 会社概要 |
|---|